https://doi.org/10.1016/s0140-6736(19)30723-8
C
Cristina Suárez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
370
Papers
14.3K
Citations
54
h-index
143
i10-index
Cristina Suárez is an academic researcher from Universitat Autònoma de Barcelona. The author has contributed to research in topics: Renal cell carcinoma treatment & Cancer Genomics and Diagnostics & Renal and related cancers. The author has an h-index of 54, co-authored 315 publications.
ORCID: 0000-0002-0502-5528Papers by this author
worksAtezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
2019 · The Lancet · 988 citations
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
2024 · New England Journal of Medicine · 274 citations
https://doi.org/10.1056/nejmoa2408154
Minimizing acquisition-related radiomics variability by image resampling and batch effect correction to allow for large-scale data analysis
2020 · European Radiology · 198 citations
https://doi.org/10.1007/s00330-020-07174-0
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
2023 · New England Journal of Medicine · 142 citations
https://doi.org/10.1056/nejmoa2212851
Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma
2020 · Investigational New Drugs · 125 citations
https://doi.org/10.1007/s10637-020-00910-9
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
2024 · New England Journal of Medicine · 120 citations
https://doi.org/10.1056/nejmoa2313906
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat